ATARA BIOTHERAPEUTICS, INC. Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$9.08 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-11.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest · last filed 2015-05-11
- ATARA BIOTHERAPEUTICS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2015-03-31 was -$9.08M.
- ATARA BIOTHERAPEUTICS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2014-12-31 was -$10.62M.
- ATARA BIOTHERAPEUTICS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2014-09-30 was -$5.93M.
- ATARA BIOTHERAPEUTICS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2014-03-31 was -$7.06M.
- ATARA BIOTHERAPEUTICS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2014 was -$28.11M.
- ATARA BIOTHERAPEUTICS, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2013 was -$8.77M.
| Period end | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 4 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|
| 2015-03-31 | -$9.08M 10-Q · filed 2015-05-11 | -$19.69M derived: sum of 2 quarters · filed 2015-05-11 | -$25.62M derived: sum of 3 quarters · filed 2015-05-11 | ||
| 2014-12-31 | -$10.62M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$16.55M derived: sum of 2 quarters · filed 2015-02-26 | -$28.11M 10-K · filed 2015-02-26 | ||
| 2014-09-30 | -$5.93M 10-Q · filed 2014-11-12 | -$17.49M 10-Q · filed 2014-11-12 | |||
| 2014-03-31 | -$7.06M 10-Q · filed 2015-05-11 | -$10.62M derived: sum of 2 quarters · filed 2015-05-11 | -$13.15M derived: sum of 3 quarters · filed 2015-05-11 | ||
| 2013-12-31 | -$3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$6.09M derived: sum of 2 quarters · filed 2015-02-26 | -$8.77M 10-K · filed 2015-02-26 | ||
| 2013-09-30 | -$2.54M 10-Q · filed 2014-11-12 | -$5.22M 10-Q · filed 2014-11-12 | |||
| 2012-12-31 | -$4.11M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |